{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A PHASE I\/II STUDY OF AKR1C3-ACTIVATED PRODRUG OBI8208;3424 (OBI-3424) IN PATIENTS WITH RELAPSED\/REFRACTORY TCELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) \/ T-CELL LYMPHOBLASTIC LYMPHOMA (T-LBL)","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-i-ii-study-of-akr1c3-activated-prodrug-obi82083424-obi-3424-in-patients-with-relapsed-refractory-tcell-acute-lymphoblastic-leukemia-t-all-t-cell-lymphoblastic-lymphoma-t-lbl\/#breadcrumbitem"}]}